Sonal Sonu/LinkedIn
Feb 14, 2026, 17:18
Sonal Sonu: A Compatible Crossmatch Does Not Guarantee Transfusion Safety
Sonal Sonu, Transfusion Medicine Specialist, posted on LinkedIn:
“A compatible crossmatch confirms serological compatibility at the time of testing – not absolute transfusion safety.
Evanescent alloantibodies and anamnestic immune responses can still result in delayed hemolytic transfusion reactions.
Safe transfusion is not just about reports.
It requires patient history, clinical context, and vigilance.
Transfusion medicine is clinical judgment – not a checkbox.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 12:03Heather Case: Bridging Awareness and Action in Women’s Hemophilia Care
-
Oct 9, 2026, 11:58Brandon Luu: Can Iron Deficiency Cause Fatigue Without Anemia?
-
Oct 9, 2026, 11:51Sumaiya Dickens: Marginal Zone B Cells in Transfusion Medicine and Hemophilia A Research
-
Oct 9, 2026, 11:44Ayyappan V Nair: PRP and Rehabilitation – Can It Help Athletes with Partial Rotator Cuff Tears?
-
Oct 9, 2026, 11:29Jigesha Dholakia: Supporting the Hemophilia Community Through the Unite Walk
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)